期刊文献+

糖尿病中医疗效评价PRO量表的反应度研究 被引量:18

Responsiveness of diabetes PRO scale of the evaluation for the efficacy of TCM
原文传递
导出
摘要 目的:考核糖尿病中医疗效评价患者报告结局(PRO)量表的反应度。方法:以550例糖尿病患者及30名非糖尿病患者为调查对象,填写完成糖尿病中医疗效评价PRO量表。本研究将调查人群按有无糖尿病、有无糖尿病并发症、不同糖化血红蛋白控制情况及糖尿病患者12周前后进行分组,分别对量表生理、心理、社会领域及总分作比较。结果:非糖尿病组的各领域得分及总分显著低于糖尿病组(P<0.01)。有糖尿病慢性并发症在生理领域及总分得分显著高于有慢性并发症患者(P<0.05),在社会及心理领域差异无统计学意义。血糖控制佳的糖尿病患者在生理、社会领域及总分得分低于血糖控制差的患者(P<0.05),在心理领域差异无统计学意义。糖尿病患者12周前后2次量表评分比较显示,糖化血红蛋白好转的同时,量表的各领域及总分评分同步下降,差异有统计学意义(P<0.05)。结论:糖尿病中医疗效评价PRO量表临床反应度较好,适合在临床疗效评价中使用。 Objective:The main purpose of this paper is through this research to evaluate the responsibility of the PRO scale.Methods:A total of 550 diabetic patients and 30 non-diabetic patients completed the PRO scale.In this study,the investigated population was divided into groups according to whether people were suffering from DM,whether the patients have DM complications,different HbA1c control conditions,and DM patients before and after 3 months.At last,we will give a pertinent evaluation to responsiveness of the PRO scale according to the result of the study.Results:The scores of non diabetic group were lower than those of diabetic patients(P<0.01).The score of chronic complications of diabetes in physiological field and total score was higher than that in patients with complications(P<0.05),and there was no statistical difference in social and psychological field.There was significant difference between the patients with good glycemic control and those with poor glycemic control in physiological,social and total scores(P<0.05),but no significant difference in psychological.The results of the two scales before and after 12 weeks showed that the score of each field and total score of the scale decreased simultaneously with the improvement of HbA1c,the difference was statistically significant(P<0.05).Conclusion:After the scientific assessment,the performance of diabetes PRO scale has been proved to have good responsibility.
作者 陈艺蕾 张晟 柴菽彬 陆灏 CHEN Yi-lei;ZHANG Sheng;CHAI Shu-bin;LU Hao(Shuguang Hospital of Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China)
出处 《中华中医药杂志》 CAS CSCD 北大核心 2020年第4期2031-2033,共3页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家自然科学基金项目(No.81874434,No.81503552) 上海市科委科研计划项目(No.17401970100,No.14401930600) 上海市中医临床重点实验室(No.14DZ2273200)。
关键词 PRO量表 反应度 糖尿病 PRO scale Responsibility Diabetes mellitus
  • 相关文献

参考文献9

二级参考文献163

共引文献201

同被引文献203

引证文献18

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部